Stock MITRA MITHRA PHARMACEUTICALS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Real-time Euronext Bruxelles
Other stock markets
 11:35:26 2024-04-26 am EDT 		5-day change 1st Jan Change
0.216 EUR -1.82% Intraday chart for Mithra Pharmaceuticals S.A. -.--% -82.78%
Apr. 29 Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 CI
Apr. 22 Mithra Pharmaceuticals Obtains Court Protection Measures MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
GL
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023
GL
Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023
CI
Mithra Pharmaceuticals Obtains Court Protection Measures
MT
Mithra secures court protection measures to advance monetization process
GL
Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses
AQ
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study
PU
Mithra reports full year 2023 financial results
GL
Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Mithra announces changes to its executive management
AQ
Mithra Pharmaceuticals to Initiate Monetization Process Involving Sale of Assets, Business
MT
Mithra Pharmaceuticals Terminates CEO; Names CFO, COO as Successors
MT
Mithra announces changes to its executive management
GL
Mithra announces changes to its executive management
AQ
Mithra initiates monetization process, receives bridge loan from existing lenders
GL
Mithra Pharmaceuticals SA Announces CEO Changes
CI
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase
AQ
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
GL
Mithra Pharmaceuticals Exits Stake in Mayne Pharma
MT
Mithra sells shares in Mayne Pharma
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MITRA Stock
  4. News Mithra Pharmaceuticals S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW